Pure Global
NCT06027372

Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis

Differences in Heart Rate Variability and Nocturnal Blood Oxygen Saturation of Patients With Idiopathic Pulmonary Fibrosis Between at Baseline and During Acute Exacerbation
Taipei Veterans General Hospital, Taiwan·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Idiopathic Pulmonary Fibrosis
Drug/Device/Intervention
LARGAN ECG Holter
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Taipei Veterans General Hospital, Taiwan
Location
Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
May 21, 2020
End date
Jun 30, 2024
Enrollment
70 participants
Primary outcome

The correlations between measures of pulmonary function test and heart rate variability

Summary

The goal of this observational study is to compare the overnight heart rate variability (HRV)
 and nocturnal oxygen saturation (SpO2) in patients with idiopathic pulmonary fibrosis (IPF).
 The main questions it aims to answer are: (1). if there are correlations between pulmonary
 function test and HRV and overnight SpO2; (2). if HRV and SpO2 can predict the occurrence of
 acute exacerbation in patients with IPF. Participants will be asked to examine pulmonary
 function test (including lung volumes and six-minute walk test) and wear pulse oxygenation
 recorder and LARGAN ECG Holter (LARGAN HEALTH TECHNOLOGY Sleep Apnea And Sleep Quality
 Examination System) during sleep.

ICD-10 classifications
Other interstitial pulmonary diseases with fibrosisCystic fibrosis with pulmonary manifestationsCystic fibrosisGraphite fibrosis (of lung)Pulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06027372
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06027372 through Pure Global AI's free database. This phase not specified trial is sponsored by Taipei Veterans General Hospital, Taiwan and is currently Recruiting. The study focuses on Idiopathic Pulmonary Fibrosis. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.